Dr. Ralph J. Devito, MD

Dr. Devito practices at Yale New Haven Psychiatric Hospital (York St) in New Haven, Connecticut.

Dr. Devito's NPI, 1093741019, was assigned on June 23, 2006. Dr. Devito graduated from Albany Medical College in 1974. Dr. Devito holds Connecticut license 019370.

Dr. Devito's primary practice is Yale New Haven Psychiatric Hospital (York St), at 20 York Street, New Haven, CT 06510. The practice phone is (203) 688-5900.

Dr. Devito's primary practice is Yale New Haven Psychiatric Hospital (York St) in New Haven, Connecticut. The medical group on file is Yale Health. Dmand AI also links Dr. Devito to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Devito practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Devito's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Devito is board certified in urology by the American Board of Urology. Dr. Devito is licensed in Connecticut.

Dmand AI lists bladder disease, enlarged prostate, erectile dysfunction, prostate cancer, urinary endoscopy, urine flow blockage and UTI among the conditions Dr. Devito treats.

CMS data shows 449 Medicare services from Dr. Devito across 7 procedure codes in 2024, for 211 Medicare patients. Medicare paid $29,524 for them.

CMS counts 211 Medicare patients who saw Dr. Devito in 2026. The largest group is 65 to 74, with 109 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Devito's median patient age at 73, with 4% women.

In 2026, Dr. Devito wrote 671 Medicare Part D claims for 232 patients. 93% of them were for generic drugs. CMS names the drug for 600 of them, across 10 drugs with 11 or more claims each, at $53,710 in total drug cost. In 2023, CMS named 892 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Devito for performance year 2026, reported as part of a group. Dr. Devito accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Devito in 2019. 2019 was the busiest year, with 3. The most frequent topics are Arteries, Embolization, Therapeutic and Prostate. Dr. Devito's most frequent co-authors are Taylor Magruder Powell, MD, Steven Harris Schoenberger, MD and Shivank S. Bhatia, MD.

CMS Open Payments shows 3 general payments to Dr. Devito from 3 drug and device companies from 2018 to 2021. Food and beverage make up the largest share, 57% of the total. Edap Technomed Inc paid the most, $104.

Dmand AI lists 1 award for Dr. Devito, most recently CMS Stage 1 EHR in 2013.

Dr. Devito graduated from Albany Medical College in 1974.

Dr. Devito is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.